NextVivo
Palo Alto
About NextVivo
NextVivo is a biotech company developing an immune organoid technology platform to transform the future of drug development. Its mission is to accelerate the development of safer, more effective therapies that are generated and tested in immune-competent human-derived models.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $7.9M
- Funding stage: Seed
- Last round: Seed (Dec 2021)
- Website: nextvivo.bio
Industries & Categories
Biotechnology
Canonical: https://fsome.com/organization/nextvivo-146531 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.